GEN Exclusives

More »

GEN Podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

A new cutting-edge but simple saliva-based DNA test can reveal how badly a spinal curvature will progress. The test will also identify those patients whose curves will remain small.


During this week's podcast Dr. Baron Lonner discusses the ScoliScoreT , which will allow physicians to predict the course of their patient's scoliosis disease. ScoliScore test results range from 1 to 200 and are broken down into three categories. The lower a score, the less likely the patient will develop a curve that is severe enough to require surgical intervention. The novel approach is expected to revolutionize the manner in which doctors manage and treat patients with scoliosis.

Dr. Baron Lonner is the Director of Scoliosis and Spine Associates, a practice dedicated to the diagnosis and comprehensive treatment of patients with scoliosis and other spinal disorders. He is presently director of the Spinal Deformity Center at NYU Hospital for Joint Diseases/NYU Medical Center, a Clinical Associate Professor of Orthopaedic Surgery at N.Y.U School of Medicine and an attending orthopaedic surgeon at Lenox Hill Hospital.

Dr. Lonner received his undergraduate and medical degrees from Boston University where he was enrolled in the accelerated six-year program. During medical school, he was honored for work on congenital scoliosis which was later presented at the prestigious Scoliosis Research Society Meeting.

He completed his residency at The Albert Einstein College of Medicine and Montefiore Medical Center. He also completed training at The Cornell University Medical Center and the Hospital for Special Surgery.

A member of the Scoliosis Research Society, North American Spine Society and The American Academy of Orthopaedic Surgery, Dr. Lonner is at the forefront of numerous innovations in scoliosis care including, spine deformity and in complex spinal reconstructive surgeries. He is also actively involved with research that offers hope for an earlier diagnosis and treatment of Idiopathic Adolescent Scoliosis and is working with geneticists and physicians across the country to help find the genetic causes for scoliosis. Additionally, he is a member of the prestigious Harms Study Group, an international scoliosis research group. He has authored and presented numerous publications and has co-authored a textbook on the surgical treatment of spinal deformities.

In addition to his work with patients at Scoliosis and Spine Associates, Dr. Lonner devotes approximately one month of his time each year to perform charitable care for patients with severe spinal deformities in developing countries. He has worked in the Dominican Republic, other parts of Latin America, and Africa.

Add a comment

  • Add a comment

  • Click here to Login/Register for free. You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?